Search

Paul R Michl

Examiner (ID: 9867)

Most Active Art Unit
1505
Art Unit(s)
1511, 3502, 1503, 2899, 1714, 1201, 1505, 1506, 3305, 1509
Total Applications
2093
Issued Applications
1688
Pending Applications
51
Abandoned Applications
353

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4156073 [patent_doc_number] => 06124431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Peptide derivatives' [patent_app_type] => 1 [patent_app_number] => 9/039426 [patent_app_country] => US [patent_app_date] => 1998-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6098 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124431.pdf [firstpage_image] =>[orig_patent_app_number] => 039426 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/039426
Peptide derivatives Mar 15, 1998 Issued
Array ( [id] => 4071999 [patent_doc_number] => 06069129 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Elastin derived composition and method of using same' [patent_app_type] => 1 [patent_app_number] => 9/039308 [patent_app_country] => US [patent_app_date] => 1998-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 7664 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/069/06069129.pdf [firstpage_image] =>[orig_patent_app_number] => 039308 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/039308
Elastin derived composition and method of using same Mar 12, 1998 Issued
Array ( [id] => 4183919 [patent_doc_number] => 06150332 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Method and composition for lowering low density lipoprotein cholesterol' [patent_app_type] => 1 [patent_app_number] => 9/038935 [patent_app_country] => US [patent_app_date] => 1998-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3955 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150332.pdf [firstpage_image] =>[orig_patent_app_number] => 038935 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/038935
Method and composition for lowering low density lipoprotein cholesterol Mar 11, 1998 Issued
09/038432 DERIVATIVES OF GLP-1 ANALOGS Mar 10, 1998 Abandoned
Array ( [id] => 4410177 [patent_doc_number] => 06228840 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Melanocortin receptor antagonists and modulations of melanocortin receptor activity' [patent_app_type] => 1 [patent_app_number] => 9/031902 [patent_app_country] => US [patent_app_date] => 1998-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7683 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228840.pdf [firstpage_image] =>[orig_patent_app_number] => 031902 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/031902
Melanocortin receptor antagonists and modulations of melanocortin receptor activity Feb 26, 1998 Issued
Array ( [id] => 4156019 [patent_doc_number] => 06103699 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Peptide, a method for its preparation and a pharmaceutical composition containing the peptide' [patent_app_type] => 1 [patent_app_number] => 9/032550 [patent_app_country] => US [patent_app_date] => 1998-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9421 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103699.pdf [firstpage_image] =>[orig_patent_app_number] => 032550 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/032550
Peptide, a method for its preparation and a pharmaceutical composition containing the peptide Feb 25, 1998 Issued
09/031122 ANTIBACTERIAL DRUGS, METHODS FOR THEIR DESIGN AND METHODS FOR THEIR USE Feb 25, 1998 Abandoned
08/952972 PEPTIDE FRAGMENTS OF TISSUE FACTOR AND THEIR USE FOR TREATMENT AND PREVENTION OF CLOTTING DISORDERS Feb 23, 1998 Abandoned
Array ( [id] => 4059395 [patent_doc_number] => 06007804 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'IL-6 as serum uric acid decreasing compound' [patent_app_type] => 1 [patent_app_number] => 9/027618 [patent_app_country] => US [patent_app_date] => 1998-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2077 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/007/06007804.pdf [firstpage_image] =>[orig_patent_app_number] => 027618 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/027618
IL-6 as serum uric acid decreasing compound Feb 22, 1998 Issued
Array ( [id] => 3945957 [patent_doc_number] => 05998376 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Substance P treatment for immunostimulation' [patent_app_type] => 1 [patent_app_number] => 9/028003 [patent_app_country] => US [patent_app_date] => 1998-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 6671 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998376.pdf [firstpage_image] =>[orig_patent_app_number] => 028003 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/028003
Substance P treatment for immunostimulation Feb 22, 1998 Issued
Array ( [id] => 4267865 [patent_doc_number] => 06245502 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Target system' [patent_app_type] => 1 [patent_app_number] => 9/026904 [patent_app_country] => US [patent_app_date] => 1998-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 10383 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245502.pdf [firstpage_image] =>[orig_patent_app_number] => 026904 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/026904
Target system Feb 18, 1998 Issued
Array ( [id] => 4088990 [patent_doc_number] => 06133233 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Peptide modulation of reperfusion injury' [patent_app_type] => 1 [patent_app_number] => 9/024975 [patent_app_country] => US [patent_app_date] => 1998-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5360 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133233.pdf [firstpage_image] =>[orig_patent_app_number] => 024975 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/024975
Peptide modulation of reperfusion injury Feb 15, 1998 Issued
Array ( [id] => 4207915 [patent_doc_number] => 06028056 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Pharmaceutical compositions for imaging and treating thrombi' [patent_app_type] => 1 [patent_app_number] => 9/020086 [patent_app_country] => US [patent_app_date] => 1998-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3644 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028056.pdf [firstpage_image] =>[orig_patent_app_number] => 020086 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/020086
Pharmaceutical compositions for imaging and treating thrombi Feb 5, 1998 Issued
09/016346 METHODS AND COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS Jan 29, 1998 Abandoned
Array ( [id] => 3949507 [patent_doc_number] => 05955431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Mast cell protease peptide inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/016366 [patent_app_country] => US [patent_app_date] => 1998-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20599 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955431.pdf [firstpage_image] =>[orig_patent_app_number] => 016366 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/016366
Mast cell protease peptide inhibitors Jan 29, 1998 Issued
Array ( [id] => 4373262 [patent_doc_number] => 06288216 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Process for isolating a protein composition from a muscle source and protein composition' [patent_app_type] => 1 [patent_app_number] => 9/015760 [patent_app_country] => US [patent_app_date] => 1998-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10108 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288216.pdf [firstpage_image] =>[orig_patent_app_number] => 015760 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/015760
Process for isolating a protein composition from a muscle source and protein composition Jan 28, 1998 Issued
09/015394 ABSORBABLE MICROPARTICLES Jan 28, 1998 Abandoned
08/983632 USE OF NEURONAL CALCIUM CHANNEL BLOCKERS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PSYCHOSES, SCHIZOPHRENIA, AND COCAINE OR AMPHETAMINE ADDICTION Jan 22, 1998 Abandoned
08/983583 METHIONINE, PENICILLAMINE AND CYSTEINE-ANALOGUE CONTAINING PEPTIDES HAVING IMMUNOMODULATING ACTIVITY Jan 21, 1998 Abandoned
09/000087 HETERODIMER PEPTIDES WITH IMMUNOMODULATORY EFFECT Jan 21, 1998 Abandoned
Menu